Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 17;16(18):3133.
doi: 10.3390/nu16183133.

The Role of Secreted Frizzled-Related Protein 5 (Sfrp5) in Overweight and Obesity in Childhood and Adolescence

Affiliations

The Role of Secreted Frizzled-Related Protein 5 (Sfrp5) in Overweight and Obesity in Childhood and Adolescence

Diamanto Koutaki et al. Nutrients. .

Abstract

Background/Objective: Secreted frizzled-related protein 5 (Sfrp5) is an anti-inflammatory adipokine that has been implicated in the pathophysiology of obesity and its metabolic complications. Despite the fact that numerous studies have been carried out in adults, limited data on Sfrp5 exist for youth, especially in relation to overweight and obesity. Methods: In our study, we assessed the concentrations of Sfrp5, total oxidative (TOS) and antioxidative (TAS) status, high-sensitivity C-reactive protein (hs-CRP), and several cytokines (IL-1α, IL-1β, IL-2, IL-6, IL-8, IL-12, TNF-α) in 120 children and adolescents (mean age ± SE: 11.48 ± 0.25 years; 48 prepubertal, 72 pubertal; 74 males and 46 females) before and 1 year after the implementation of a personalized, structured, lifestyle intervention program of healthy diet, sleep, and physical exercise. Results: Based on the body mass index (BMI), participants were categorized as having morbid obesity (n = 63, 52.5%), obesity (n = 21, 17.5%), overweight (n = 22, 18.33%), or normal BMIs (n = 14, 11.67%), based on the International Obesity Task Force (IOTF) cut-off points. Following the 1-year lifestyle intervention program, a significant improvement in anthropometric measurements (BMI, BMI-z score, diastolic blood pressure, WHR, and WHtR), body-composition parameters, hepatic enzymes, lipid profile, inflammation markers, and the insulin-sensitivity profile (HbA1C, HOMA index) was observed in all subjects. Sfrp5 decreased in subjects with obesity (p < 0.01); however, it increased significantly (p < 0.05) in patients with morbid obesity. Linear regression analysis indicates that TNF-α and systolic blood pressure were the best positive predictors and hs-CRP was the best negative predictor for Sfpr5 concentration at initial assessment and glucose concentration for ΔSfrp5, while TNF-α and TAS were the best positive predictors for Sfpr5 concentration at annual assessment. Conclusions: These results indicate that Sfrp5 is associated with severe obesity and is increased following weight loss in children and adolescents with morbid obesity. It is also related to metabolic homeostasis, as well as inflammation and oxidative status.

Keywords: Sfrp5; adolescence; childhood; obesity; overweight.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.

Figures

Figure 1
Figure 1
Concentrations of Sfrp5 at initial and annual assessment. The asterisk (*) indicates statistically significant difference.
Figure 2
Figure 2
BMI z-score at initial and annual assessment based on BMI category. *: indicates significant difference from initial assessment. †: indicates significant difference from subjects with morbid obesity. ‡: indicates significant difference from subjects with obesity. #: Indicates significant difference from subjects with overweight.

Similar articles

Cited by

References

    1. Obesity and Overweight. [(accessed on 19 April 2024)]. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
    1. Harrison J.E., Weber S., Jakob R., Chute C.G. ICD-11: An international classification of diseases for the twenty-first century. BMC Med. Inform. Decis. Mak. 2021;21:206. doi: 10.1186/s12911-021-01534-6. - DOI - PMC - PubMed
    1. Cypess A.M. Reassessing Human Adipose Tissue. N. Engl. J. Med. 2022;386:768–779. doi: 10.1056/NEJMra2032804. - DOI - PubMed
    1. Lehr S., Hartwig S., Sell H. Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders. Proteom. Clin. Appl. 2012;6:91–101. doi: 10.1002/prca.201100052. - DOI - PubMed
    1. Salans L.B., Cushman S.W., Weismann R.E. Studies of human adipose tissue. Adipose cell size and number in nonobese and obese patients. J. Clin. Investig. 1973;52:929–941. doi: 10.1172/JCI107258. - DOI - PMC - PubMed

LinkOut - more resources